Catalyst Wire Dossier Catalyst Wire Dossier

XELOXRT

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XELOXRT, covering 2012-07-31 to 2012-07-31. Get the full timeline:

Most recent: Clinical Trial Update: Preoperative Downstaging of Extraperitoneal T3 Rectal Cancer: XELOXRT Versus XELACRT. A Multicenter, Phase III Study [Phase 3]

See pricing